Insulin-like growth factor (IGF)-I modulates endothelial blood-brain barrier function in ischemic middle-aged female rats

Endocrinology

Volumn 157, Issue 1, 2016, Pages 61-69

  Bake, Shameena ^a   Okoreeh, Andre K ^a   Alaniz, Robert C ^a   Sohrabji, Farida ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE; INTERLEUKIN 2 RECEPTOR ALPHA; OXYGEN; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXP3; DRUG IMPLANT; IGF1 PROTEIN, HUMAN; NERVE PROTEIN; RECOMBINANT PROTEIN; SOMATOMEDIN C RECEPTOR;

ADULT; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN INFARCTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; EX VIVO STUDY; EXPERIMENTAL CEREBRAL ISCHEMIA; FEMALE; FLOW MEASUREMENT; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTERNALIZATION; MIDDLE AGED; MIDDLE CEREBRAL ARTERY OCCLUSION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; CELL CULTURE; CELL HYPOXIA; DRUG EFFECTS; DRUG IMPLANT; GENETICS; HUMAN; HYPOGLYCEMIA; IMMUNOLOGY; METABOLISM; MICROVASCULATURE; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STROKE; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; CELL HYPOXIA; CELLS, CULTURED; CEREBRUM; DRUG IMPLANTS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; LEUKOCYTES, MONONUCLEAR; MICROVESSELS; NERVE TISSUE PROTEINS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STROKE;

EID: 84954546140     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1840     Document Type: Article

References (53)

1. Andersen KK, Andersen ZJ, Olsen TS. Age- and gender-specific prevalence of cardiovascular risk factors in 40, 102 patients with first-ever ischemic stroke: a Nationwide Danish Study. Stroke. 2010;41:2768-2774.
2. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. A midlife stroke surge among women in the United States. Neurology. 2007;69:1898-1904.
3. Selvamani A, Sohrabji F. The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J Neurosci. 2010;30:6852-6861.
4. Selvamani A, Sohrabji F. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging. 2010;31:1618-1628.
5. Muller AP, Fernandez AM, Haas C, Zimmer E, Portela LV, Torres-Aleman I. Reduced brain insulin-like growth factor I function during aging. Mol Cell Neurosci. 2012;49:9-12.
6. Andersson IK, Edwall D, Norstedt G, Rozell B, Skottner A, Hansson HA. Differing expression of insulin-like growth factor I in the developing and in the adult rat cerebellum. Acta Physiol Scand. 1988;132:167-173.
7. Shemer J, Raizada MK, Masters BA, Ota A, Le Roith D. Insulin-like growth factor I receptors in neuronal and glial cells. Characterization and biological effects in primary culture. J Biol Chem. 1987;262:7693-7699.
8. Liu X, Yao DL, Bondy CA, et al. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol Cell Neurosci. 1994;5:418-430.
9. Torres-Aleman I, Naftolin F, Robbins RJ. Trophic effects of insulinlike growth factor-I on fetal rat hypothalamic cells in culture. Neuroscience. 1990;35:601-608.
10. Chisalita SI, Arnqvist HJ. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab. 2004;286:E896-E901.
11. Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol SerABiol SciMed Sci. 2012;67:599-610.
12. Chesik D, Glazenburg K, Wilczak N, Geeraedts F, De Keyser J. Insulin-like growth factor binding protein-1-6 expression in activated microglia. Neuroreport. 2004;15:1033-1037.
13. Smith AM, Gibbons HM, Oldfield RL, et al. M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia. J Neuroinflammation. 2013;10:85.
14. Hetman M, Cavanaugh JE, Kimelman D, Xia Z. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal. J Neurosci. 2000;20:2567-2574.
15. Rangone H, Poizat G, Troncoso J, et al. The serum- and glucocorticoidinduced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci. 2004;19:273-279.
16. Abbott NJ, Hughes CC, Revest PA, Greenwood J. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci. 1992;103(Pt 1):23-37.
17. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16:1-13.
18. Bake S, Selvamani A, Cherry J, Sohrabji F. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One. 2014;9:e91427.
19. Nilupul Perera M, Ma HK, Arakawa S, et al. Inflammation following stroke. J Clin Neurosci. 2006;13:1-8.
20. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Postischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J. 2009;276:13-26.
21. Del Zoppo GJ, Becker KJ, Hallenbeck JM. Inflammation after stroke: is it harmful? Arch Neurol. 2001;58:669-672.
22. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184:53-68.
23. Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849-1857.
24. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87:779-789.
25. Bake S, Sohrabji F. 17β-Estradiol differentially regulates bloodbrain barrier permeability in young and aging female rats. Endocrinology. 2004;145:5471-5475.
26. Jezierski MK, Sohrabji F. Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging. 2001;22:309-319.
27. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med. 1989;170:1387-1407.
28. Schnitzer JE. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol. 1992;262:H246-H254.
29. John TA, Vogel SM, Tiruppathi C, Malik AB, Minshall RD. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol. 2003;284:L187-L196.
30. Samson Y, Lapergue B, Hosseini H. Inflammation and ischaemic stroke: current status and future perspectives [in French]. Revue Neurol (Paris). 2005;161:1177-1182.
31. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 2006;66:232-245.
32. Banerjee A, Wang J, Bodhankar S, Vandenbark AA, Murphy SJ, Offner H. Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice. Transl Stroke Res. 2013;4:554-563.
33. + regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis. 2011;26:87-90.
34. Gu L, Jian Z, Stary C, Xiong X. T cells and cerebral ischemic stroke. Neurochem Res. 2015;40:1786-1791.
35. Hurn PD, Subramanian S, Parker SM, et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007;27:1798-1805.
36. Subramanian S, Zhang B, Kosaka Y, et al. Recombinant T cell receptor ligand treats experimental stroke. Stroke. 2009;40:2539-2545.
37. Zhu W, Dotson AL, Libal NL, et al. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice. Neuroscience. 2015;288:112-119.
38. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15:192-199.
39. Kleinschnitz C, Wiendl H. Con: Regulatory T cells are protective in ischemic stroke. Stroke. 2013;44:e87-e88.
40. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology. 1997;138:3515-3520.
41. Lopez-Lopez C, Le Roith D, Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA. 2004;101:9833-9838.
42. Hellström A, Carlsson B, Niklasson A, et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab. 2002;87:3413-3416.
43. Smith LE, Shen W, Perruzzi C, et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulinlike growth factor-1 receptor. Nat Med. 1999;5:1390-1395.
44. Sharma HS. Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. AnnNYAcad Sci. 2005;1053:407-421.
45. Liu X, Yao DL, Webster H. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis. Mult Scler. 1995;1:2-9.
46. Pang Y, Zheng B, Campbell LR, Fan LW, Cai Z, Rhodes PG. IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain. Pediatr Res. 2010;67:579-584.
47. Odena G, Miquel M, Serafín A, et al. Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats. World J Gastroenterol. 2012;18:2084-2091.
48. Hussain MA, Studer K, Messmer EP, Froesch ER. Treatment with insulin-like growth factor I alters capillary permeability in skin and retina. Diabetes. 1995;44:1209-1212.
49. Berezowski V, Fukuda AM, Cecchelli R, Badaut J. Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology. Int J Cell Biol. 2012;2012:176287.
50. Lo EH, Broderick JP, Moskowitz MA. tPA and proteolysis in the neurovascular unit. Stroke. 2004;35:354-356.
51. Del Zoppo GJ. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev. 1994;6:47-96.
52. Gursoy-Ozdemir Y, Yemisci M, Dalkara T. Microvascular protection is essential for successful neuroprotection in stroke. J Neurochem. 2012;123(suppl 2):2-11.
53. Kaur J, Tuor UI, Zhao Z, Barber PA. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly. J Cereb Blood Flow Metab. 2011;31:1874-1885.